Ethics as Our Guide

In their essay in the April 2004 issue of PLoS Biology, Elizabeth Blackburn and Janet Rowley (2004), two distinguished cellular biologists and members of the President’s Council on Bioethics, strongly question the scientifi c foundation of two reports from the Council (President’s Council on Bioethics 2003, 2004). The Council on Bioethics was formed by executive order “to advise the President on bioethical issues that may emerge as a consequence of advances in biomedical science and technology.” An open discussion between ethicists and scientists is critical to the advisory system. The recent administrative dismissal of Dr. Blackburn from the Council is very alarming. By stacking the deck with conservative opinions, and not accurately discussing the scientifi c issues, the Bioethics Council has become irrelevant to the scientifi c community and presents a jaundiced view to the public. Stem cell research and its applications have the potential to revolutionize human health care. Recent polls show support for embryonic stem cell research, even with conservative voters. The public, as the major benefactor of biomedical research and the target population of benefi cial clinical advances, has the right to a fact-based discussion of the science regarding stem cells. It is therefore time that the debate on stem cell research, with its risks and benefi ts, be taken to the public. A debate on stem cell research restricted to the President’s Council on Bioethics is a disservice to the public. Nearly three decades ago, the advent of recombinant DNA technology and in vitro fertilization (IVF) techniques, raised similar concerns regarding research. Contrary to apprehensive expectations, recombinant DNA technology has boosted enormous advances in the health care and pharmaceutical industry. IVF evolved to be a widely accepted, safe medical